February 4, 2021

Pharmaceutical giant Johnson & Johnson on Thursday applied for emergency permission of its one-dose COVID-19 vaccine

The company’s shot is 66 percent effectiv e against moderate to severe cases of the deadly global pandemic, however it just requires a single dosage and offers strong protection against hospitalization and death from the bug, Politico reported

The J&J vaccine would add an essential third choice– along with Pfizer and Moderna shots– as the United States struggles to disperse vaccines against the coronavirus, which has actually killed more than 455,000 Americans, according to Johns Hopkins University, which is tracking the infection.

Nevertheless, the J&J version has shown less reliable against a more aggressive stress of the infection found in South Africa, the report said.

That strain, along with an alternative recognized in the UK, has been identified in the United States.

Nonetheless, the J&J vaccine provides a third line of defense.

” Upon permission of our investigational COVID-19 vaccine for emergency usage, we are prepared to begin shipping,” Paul Stoffels, the business’s chief scientific officer, said in a declaration. “We are dealing with excellent urgency to make our investigational vaccine offered to the general public as quickly as possible.”